Novel Nanotechnology Approaches for Oral Cancer Treatment – Prelims Specific

Introduction

The application of nanotechnology in oncology represents a significant advancement in medical science. By focusing on targeted drug delivery, researchers are addressing the limitations of systemic treatments like chemotherapy, which often result in high toxicity to healthy tissues.

Why in News?

• Researchers at the Indian Institute of Science (IISc), Bengaluru, have successfully demonstrated a nanoparticle-based delivery system designed to treat oral cancer.
• The method utilizes stimuli-responsive mechanisms to ensure drugs are released specifically within the tumor microenvironment.

Static Link

• The issue relates to the Science and Technology syllabus (Biotechnology and Healthcare).
• It involves the concept of Targeted Drug Delivery Systems (TDDS), which aim to maximize the therapeutic index of drugs by directing them to specific cells or tissues.
• UPSC often examines the intersection of materials science (nanotechnology) and clinical applications (medicine).

Institutional Link

• Indian Institute of Science (IISc), Bengaluru: A premier public research university, it functions under the administrative control of the Ministry of Education.
• Department of Biotechnology (DBT): A department under the Ministry of Science and Technology, it plays a key role in funding and fostering R&D in biotechnological innovations.

Core Prelims Facts

• Nanoparticles are typically defined as structures ranging from 1 to 100 nanometres.
• Targeted therapy aims to minimize collateral damage to healthy cells compared to systemic chemotherapy.
• The IISc method relies on the unique conditions of the tumor microenvironment, such as specific pH levels or enzymes, to trigger drug release.

Important Terms and Concepts

• Targeted Drug Delivery System (TDDS): A method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others.
• Therapeutic Index: The ratio between the toxic dose and the effective dose of a drug; a higher index generally implies a safer drug.
• Precision Medicine: A medical model that proposes the customization of healthcare, with medical decisions, practices, and products being tailored to the individual patient or tumor characteristics.

Possible UPSC Prelims Traps

• Assumption Trap: It is incorrect to assume that targeted drug delivery increases systemic toxicity; in fact, it is designed to significantly reduce it.
• Definition Trap: UPSC may swap the definition of nanotechnology or confuse stimuli-responsive triggers with non-specific delivery methods.
• Institutional Trap: Confusion between the funding Ministry (Ministry of Science and Technology) and the status of the university (Deemed to be University under the Ministry of Education).
• Absolute Statement Trap: Statements claiming that targeted delivery eliminates all side effects are likely false, as the goal is to minimize them, not necessarily eliminate them entirely.

One-Minute Revision Notes

• Nanotechnology in medicine is categorized under Applied Biotechnology.
• Targeted drug delivery systems are designed to bypass healthy tissue, thereby reducing systemic toxicity.
• Stimuli-responsive mechanisms in drug delivery react to factors like pH or enzymatic changes at the tumor site.
• IISc is a prominent research institution contributing to India's shift toward precision medicine.

Practice MCQ for Prelims

1. Consider the following statements regarding Targeted Drug Delivery Systems (TDDS) in cancer treatment:

1. They are designed to increase the systemic concentration of chemotherapy drugs in the blood.

2. Nanoparticles can be engineered to release drugs in response to specific triggers like pH levels in the tumor microenvironment.

Which of the statements given above is/are correct?

A) 1 only

B) 2 only

C) Both 1 and 2

D) Neither 1 nor 2

Answer: B

Explanation: Statement 1 is incorrect because TDDS aims to reduce systemic concentration and toxicity, not increase it. Statement 2 is correct as nanoparticles can be designed to respond to physiological triggers specific to the tumor site.